- Investing Ideas
- /
- Swedish Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Swedish Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Results
3
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
3 companies
Saniona
Market Cap: SEK 1.6b
A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, the United States, Germany, Denmark, and the United Kingdom.
SANION
SEK 11.72
7D
0.9%
1Y
144.9%
BioGaia
Market Cap: SEK 10.7b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 105.60
7D
2.4%
1Y
-9.4%
Genovis AB (publ.)
Market Cap: SEK 1.6b
Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
GENO
SEK 25.10
7D
7.5%
1Y
9.1%